Xavo, a leading provider of Software-as-a-Service for Biopharma R&D with offices in Boston, MA, Bayreuth, Germany and Basel, Switzerland, is pleased to announce that Synthego has gone live with Xavo R3. - “We are very happy to add Synthego to our growing list of North American clients”, says Reda Bensaid, Xavo’s CEO.
Synthego, a California-based Genome Engineering company who is pioneering the genome editing space to accelerate the development of next generation cell therapies, has turned to Xavo in 2022 for an innovative Sample Management solution helping to optimally place and later find sample containers in multiple freezers across multiple sites while avoiding user error in the check-in and check-out process. Following Xavo’s standard process and out-of-the-box product functionality, the joint team was able to configure and integrate a solution for Synthego within a very short period.
“At Synthego, we leverage the latest technologies in Software and Automation to support our cause to provide genome editing at scale”, says Arne Vandenbroucke, PhD, Director, Automation and Systems Engineering at Synthego. He continues: “We are very happy with how the Xavo solution helps us to increase productivity in the lab by providing accurate inventory information about sample availability and location as well as user guidance in all inventory operations. What makes the difference for us is the excellent User Experience leading to reduced operator onboarding time and reduced operator errors.”
Rami Lokas, Xavo’s VP Value Realization says: “We are grateful for the great collaboration with the Synthego team, who allowed us to deliver a state-of-the-art Sample Management solution that ensures data integrity when executing production tasks across multiple sites within a relatively short amount of time. And because Xavo is provided as SaaS, Synthego will continue to benefit from additional functionality and improvements on an ongoing basis at no additional cost.”